Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS

Clinical trial NCT02273635 · UNKNOWN

Trial details

NCT number: NCT02273635
Sponsor: Innobioscience SpA
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Progressive Multiple Sclerosis Multiple Sclerosis, Secondary Progressive

Start date: 2014-09-01
Primary completion: 2016-11-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.